KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q3 2025

Type / Class
Debt / NOTE 6.000% 5/1
Market price (% of par)
73.54%
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal
$102,115,871
Total reported market value
$79,947,428
Principal change
$0
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 4 institutional investors reported holding $102,115,871 in principal (par value) of KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1.

Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q3 $102,115,871 $79,947,428 73.54% 4
2025 Q2 $102,115,871 $79,512,797 +$79,512,797 74.14% 4
2024 Q4 $0 $0 -$5,943,570 73.54% 0
2024 Q3 $8,871 $5,943,570 +$5,943,570 67000.0% 1